RNAM NASDAQ
Avidity Biosciences Inc
1W: -1.9%
1M: -1.7%
YTD: -1.8%
$72.86
Last traded 2026-03-03 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$19M
+72.1% ▲
Gross Profit
$15M
+79.8% ▲
Operating Income
-$746M
-96.9% ▼
Net Income
-$685M
-112.4% ▼
EPS (Diluted)
$-4.97
-72.0% ▼
EBITDA
-$742M
-97.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2025 |
|---|---|
| Revenue | $19M |
| YoY Growth | +72.1% |
| Cost of Revenue | $4M |
| Gross Profit | $15M |
| Gross Margin | 77.9% |
| R&D Expenses | $559M |
| SG&A Expenses | $201M |
| Operating Expenses | $761M |
| Operating Income | -$746M |
| Operating Margin | -3977.3% |
| Interest Expense | $0 |
| Income Before Tax | -$685M |
| Tax Expense | $0 |
| Net Income | -$685M |
| Net Margin | -3650.4% |
| EPS (Diluted) | $-4.97 |
| EBITDA | -$742M |
| Shares Outstanding | 138M |